Gqg Partners LLC Novartis Ag Transaction History
Gqg Partners LLC
- $64.8 Billion
- Q3 2025
A detailed history of Gqg Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Gqg Partners LLC holds 2,262,867 shares of NVS stock, worth $298 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
2,262,867
Previous 62,535
3518.56%
Holding current value
$298 Million
Previous $7.57 Million
3734.94%
% of portfolio
0.45%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...